VYNE Therapeutics Inc. VYNE
28.56 USD 0.00 (+0.00%)
At closeJul 27, 2026, 4:00 PM EDT
0.65 -27.91 -97.73%
After hours · Jul 27, 4:00 PM ET
23.37 Day range 28.72
1.57 52-week range 3.43
- YTD
- +4,824.14%
- 1 year
- +1,662.96%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 570.00K | 501.00K | 424.00K | 477.00K | 931.00K | |
| 570.00K | 501.00K | 424.00K | 477.00K | 931.00K | |
| -29.75M | -43.64M | -29.26M | -34.30M | -38.91M | |
| -26.48M | -39.83M | -28.45M | -23.21M | -73.33M | |
| -31.00 | -46.50 | -139.00 | -364.00 | -1,282.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 24.03M | 19.93M | 30.67M | 30.98M | 42.85M | |
| 30.16M | 66.91M | 97.69M | 40.76M | 67.05M | |
| 2.40M | 14.82M | 8.95M | 9.35M | 18.41M | |
| 27.77M | 52.09M | 88.73M | 31.20M | 48.64M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -33.12M | -33.97M | -25.34M | -29.20M | -56.37M | |
| 37.37M | 23.36M | -57.35M | 15.67M | 1.03M | |
| -143.00K | -141.00K | 82.39M | 1.65M | 39.78M | |
| 4.10M | -10.75M | -301.00K | -11.88M | -15.56M |